BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29548697)

  • 1. Nanoparticles against resistant Pseudomonas spp.
    Venegas MA; Bollaert MD; Jafari A; Bondoc JMG; Twilley J; Thompson W; Movahedzadeh F
    Microb Pathog; 2018 May; 118():115-117. PubMed ID: 29548697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limonia acidissima L. leaf mediated synthesis of silver and zinc oxide nanoparticles and their antibacterial activities.
    Patil BN; Taranath TC
    Microb Pathog; 2018 Feb; 115():227-232. PubMed ID: 29248515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of the antimicrobial activity of silver and zinc oxide nanoparticles against fish pathogens.
    Shaalan MI; El-Mahdy MM; Theiner S; El-Matbouli M; Saleh M
    Acta Vet Scand; 2017 Jul; 59(1):49. PubMed ID: 28732514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZnO, TiO2 and Ag nanoparticles impact against some species of pathogenic bacteria and yeast.
    Mohammed AK; Salh KK; Ali FA
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):24-34. PubMed ID: 34933736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bio-functionalization of phytogenic Ag and ZnO nanobactericides onto cellulose films for bactericidal activity against multiple drug resistant pathogens.
    Baker S; Prudnikova SV; Shumilova AA; Perianova OV; Zharkov SM; Kuzmin A
    J Microbiol Methods; 2019 Apr; 159():42-50. PubMed ID: 30797021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of silver nanoparticles (Axonnite) on clinical and environmental strains of Acinetobacter spp.
    Łysakowska ME; Ciebiada-Adamiec A; Klimek L; Sienkiewicz M
    Burns; 2015 Mar; 41(2):364-71. PubMed ID: 25145873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoantibiotics: strategic assets in the fight against drug-resistant superbugs.
    Khurana C; Chudasama B
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):3-6. PubMed ID: 29593387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailoring shape and size of biogenic silver nanoparticles to enhance antimicrobial efficacy against MDR bacteria.
    Kumari M; Pandey S; Giri VP; Bhattacharya A; Shukla R; Mishra A; Nautiyal CS
    Microb Pathog; 2017 Apr; 105():346-355. PubMed ID: 27889528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
    Yuan YG; Peng QL; Gurunathan S
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of antibiotic resistance and induction of a stress response in Pseudomonas aeruginosa by silver nanoparticles.
    Markowska K; Grudniak AM; Krawczyk K; Wróbel I; Wolska KI
    J Med Microbiol; 2014 Jun; 63(Pt 6):849-854. PubMed ID: 24623636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial resistance to silver nanoparticles and how to overcome it.
    Panáček A; Kvítek L; Smékalová M; Večeřová R; Kolář M; Röderová M; Dyčka F; Šebela M; Prucek R; Tomanec O; Zbořil R
    Nat Nanotechnol; 2018 Jan; 13(1):65-71. PubMed ID: 29203912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergetic antibacterial activity of Ag islands on ZnO (Ag/ZnO) heterostructure nanoparticles and its mode of action.
    Zhang Y; Gao X; Zhi L; Liu X; Jiang W; Sun Y; Yang J
    J Inorg Biochem; 2014 Jan; 130():74-83. PubMed ID: 24176922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa.
    Chen Q; Shah KN; Zhang F; Salazar AJ; Shah PN; Li R; Sacchettini JC; Wooley KL; Cannon CL
    Mol Pharm; 2019 Apr; 16(4):1606-1619. PubMed ID: 30817887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria.
    Cavassin ED; de Figueiredo LF; Otoch JP; Seckler MM; de Oliveira RA; Franco FF; Marangoni VS; Zucolotto V; Levin AS; Costa SF
    J Nanobiotechnology; 2015 Oct; 13():64. PubMed ID: 26438142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread and Indiscriminate Nanosilver Use: Genuine Potential for Microbial Resistance.
    Gunawan C; Marquis CP; Amal R; Sotiriou GA; Rice SA; Harry EJ
    ACS Nano; 2017 Apr; 11(4):3438-3445. PubMed ID: 28339182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial properties of biosynthesized silver nanoparticles studied by flow cytometry and related techniques.
    Railean-Plugaru V; Pomastowski P; Rafinska K; Wypij M; Kupczyk W; Dahm H; Jackowski M; Buszewski B
    Electrophoresis; 2016 Mar; 37(5-6):752-61. PubMed ID: 26763104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold-, silver- and magnesium-doped zinc oxide nanoparticles prevents the formation of and eradicates bacterial biofilms.
    Jorge EC; Martínez NN; González MJ; Sánchez SV; Robino L; Morales JO; Scavone P
    Nanomedicine (Lond); 2023 Apr; 18(10):803-818. PubMed ID: 37254888
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of antibacterial efficacy of phyto fabricated silver nanoparticles using Mukia scabrella (Musumusukkai) against drug resistance nosocomial gram negative bacterial pathogens.
    Prabakar K; Sivalingam P; Mohamed Rabeek SI; Muthuselvam M; Devarajan N; Arjunan A; Karthick R; Suresh MM; Wembonyama JP
    Colloids Surf B Biointerfaces; 2013 Apr; 104():282-8. PubMed ID: 23334182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TiO2 nanotube composite layers as delivery system for ZnO and Ag nanoparticles - an unexpected overdose effect decreasing their antibacterial efficacy.
    Roguska A; Belcarz A; Pisarek M; Ginalska G; Lewandowska M
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():158-66. PubMed ID: 25842121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel combination of nanoparticles and metallo-β-lactamase inhibitor/antimicrobial-based formulation to combat antibiotic resistant Enterococcus sp. and Pseudomonas sp. strains.
    Caballero Gómez N; Manetsberger J; Benomar N; Abriouel H
    Int J Biol Macromol; 2023 Sep; 248():125982. PubMed ID: 37499723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.